References
- Ou H, Liu C, Feng W, Xiao X, Tang S, Mo Z. Role of AMPK in atherosclerosis via autophagy regulation. Sci China Life Sci. 2018;61:1212-1221. https://doi.org/10.1007/s11427-017-9240-2
- Boudoulas KD, Triposciadis F, Geleris P, Boudoulas H. Coronary atherosclerosis: pathophysiologic basis for diagnosis and management. Prog Cardiovasc Dis. 2016;58:676-692. https://doi.org/10.1016/j.pcad.2016.04.003
- Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692-702. https://doi.org/10.1161/CIRCRESAHA.115.306361
- Wang J, Uryga AK, Reinhold J, Figg N, Baker L, Finigan A, Gray K, Kumar S, Clarke M, Bennett M. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132:1909-1919. https://doi.org/10.1161/CIRCULATIONAHA.115.016457
- Johnson JL. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc Res. 2014;103:452-460. https://doi.org/10.1093/cvr/cvu171
- Hutcheson JD, Goettsch C, Bertazzo S, Maldonado N, Ruiz JL, Goh W, Yabusaki K, Faits T, Bouten C, Franck G, Quillard T, Libby P, Aikawa M, Weinbaum S, Aikawa E. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater. 2016;15:335-343. https://doi.org/10.1038/nmat4519
- Jiang XI, Luo Y, Zhao S, Chen Q, Jiang C, Dai Y, Chen Y, Cao Z. Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction. Exp Ther Med. 2015;10:213-218. https://doi.org/10.3892/etm.2015.2443
- Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011;215:286-293. https://doi.org/10.1016/j.atherosclerosis.2010.12.024
- Ambros V. The functions of animal microRNAs. Nature. 2004;431:350-355. https://doi.org/10.1038/nature02871
- Ndrepepa G, Colleran R, Kastrati A. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. Clin Chim Acta. 2018;476:130-138. https://doi.org/10.1016/j.cca.2017.11.026
- Xu Z, Han Y, Liu J, Jiang F, Hu H, Wang Y, Liu Q, Gong Y, Li X. miR-135b-5p and miR-499a-3p promote cell proliferation and migration in atherosclerosis by directly targeting MEF2C. Sci Rep. 2015;5:12276. https://doi.org/10.1038/srep12276
- Zhang R, Sui L, Hong X, Yang M, Li W. miR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C. Environ Sci Pollut Res Int. 2017;24:22294-22300. https://doi.org/10.1007/s11356-017-9771-1
- Lin B, Feng DG, Wang F, Wang JX, Xu CG, Zhao H, Cheng ZY. miR-365 participates in coronary atherosclerosis through regulating IL-6. Eur Rev Med Pharmacol Sci. 2016;20:5186-5192.
- Lu L, Cai M, Peng M, Wang F, Zhai X. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer. Cancer Manag Res. 2019;11:1805-1816. https://doi.org/10.2147/CMAR.S183085
- Guo J, Luo C, Yang Y, Dong J, Guo Z, Yang J, Lian H, Ye C, Liu M. miR-491-5p, as a tumor suppressor, prevents migration and invasion of breast cancer by targeting ZNF-703 to regulate AKT/mTOR pathway. Cancer Manag Res. 2021;13:403-413. https://doi.org/10.2147/CMAR.S279747
- Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang X, Zhao L, Huang C. miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer. Cell Death Dis. 2017;8:e2714. https://doi.org/10.1038/cddis.2017.134
- He Z, Wang Y, He Q, Chen M. microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9. Open Med (Wars). 2020;15:492-500. https://doi.org/10.1515/med-2020-0047
- Yuan M, Zhan Q, Duan X, Song B, Zeng S, Chen X, Yang Q, Xia J. A functional polymorphism at miR-491-5p binding site in the 3'-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population. Atherosclerosis. 2013;226:447-452. https://doi.org/10.1016/j.atherosclerosis.2012.11.026
- Woo CC, Liu W, Lin XY, Dorajoo R, Lee KW, Richards AM, Lee CN, Wongsurawat T, Nookaew I, Sorokin V. The interaction between 30b-5p miRNA and MBNL1 mRNA is involved in vascular smooth muscle cell differentiation in patients with coronary atherosclerosis. Int J Mol Sci. 2019;21:11. https://doi.org/10.3390/ijms21010011
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
- Song Z, Li G. Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res. 2010;3:246-250. https://doi.org/10.1007/s12265-010-9163-0
- Chen Q, Yang F, Guo M, Wen G, Zhang C, Luong le A, Zhu J, Xiao Q, Zhang L. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration. J Mol Cell Cardiol. 2015;89(Pt A):75-86. https://doi.org/10.1016/j.yjmcc.2015.10.017
- Davis-Dusenbery BN, Wu C, Hata A. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler Thromb Vasc Biol. 2011;31:2370-2377. https://doi.org/10.1161/ATVBAHA.111.226670
- Albinsson S, Sessa WC. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics. 2011;43:529-533. https://doi.org/10.1152/physiolgenomics.00146.2010
- Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 2010;10:36-46. https://doi.org/10.1038/nri2675
- Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325. https://doi.org/10.1038/nature10146
- Pordzik J, Pisarz K, De Rosa S, Jones AD, Eyileten C, Indolfi C, Malek L, Postula M. The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review. Front Endocrinol (Lausanne). 2018;9:74. https://doi.org/10.3389/fendo.2018.00074
- Fasolo F, Di Gregoli K, Maegdefessel L, Johnson JL. Non-coding RNAs in cardiovascular cell biology and atherosclerosis. Cardiovasc Res. 2019;115:1732-1756. https://doi.org/10.1093/cvr/cvz203
- Hueso M, Mallen A, Casas A, Guiteras J, Sbraga F, Blasco-Lucas A, Lloberas N, Torras J, Cruzado JM, Navarro E. Integrated miRNA/ mRNA counter-expression analysis highlights oxidative stressrelated genes CCR7 and FOXO1 as blood markers of coronary arterial disease. Int J Mol Sci. 2020;21:1943. https://doi.org/10.3390/ijms21061943
- He Y, Lin L, Cao J, Mao X, Qu Y, Xi B. Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1. Int J Clin Exp Med. 2015;8:674-681.
- Fan JL, Zhang L, Bo XH. miR-126 on mice with coronary artery disease by targeting S1PR2. Eur Rev Med Pharmacol Sci. 2020;24:893-904.